ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,770Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 2456

$566K Total Retail Price of All Prescriptions

Rank: 178 out of 2456

775 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 775 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 775 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,663 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 1,106 917 1 1
SIMVASTATIN 849 713 2 2
OMEPRAZOLE 618 435 3 3
HYDROCHLOROTHIAZIDE 605 559 4 7
AMLODIPINE BESYLATE 507 465 5 5
ATENOLOL 442 417 6 6
LEVOTHYROXINE SODIUM 425 351 7 4
METFORMIN HCL 382 308 8 11
METOPROLOL TARTRATE 373 298 9 10
FUROSEMIDE 353 313 10 8
ATORVASTATIN CALCIUM 325 273 11 12
GABAPENTIN 242 171 12 16
OXYCODONE-ACETAMINOPHEN 231 74 S2 13 35
PRAVASTATIN SODIUM 221 187 14 15
SERTRALINE HCL 220 172 15 21
WARFARIN SODIUM 189 138 16 9
METOPROLOL SUCCINATE 182 144 17 13
PROAIR HFA 163 95 18 22
ZOLPIDEM TARTRATE 160 117 19 28
DIOVAN 144 133 20 26
FLUTICASONE PROPIONATE 141 99 21 30
GLIPIZIDE 131 117 22 46
LOSARTAN POTASSIUM 131 122 22 18
TAMSULOSIN HCL 125 120 24 32
GLYBURIDE 124 120 R 25 40
LOVASTATIN 109 89 26 34
TRAZODONE HCL 108 62 27 17
ALLOPURINOL 107 96 28 27
DONEPEZIL HCL 105 100 29 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 74 30 41
ALENDRONATE SODIUM 102 97 31 19
CLONIDINE HCL 97 88 32 111
FLUOXETINE HCL 94 52 33 45
FLOVENT HFA 94 68 33 104
CLOPIDOGREL 92 80 35 55
PAROXETINE HCL 83 48 36 56
TRAMADOL HCL 77 42 37 24
LORAZEPAM 75 74 38 67
INSULIN SYRINGE 73 39 39 72
IBUPROFEN 72 34 40 52
HYDROCODONE-ACETAMINOPHEN 71 36 S3 41 20
OXYCODONE HCL 68 32 S2 42 38
LANTUS 67 37 43 44
NAPROXEN 66 14 44 109
NAMENDA 64 64 45 42
PREDNISONE 64 49 45 39
PANTOPRAZOLE SODIUM 64 50 45 37
CARVEDILOL 64 58 45 54
CITALOPRAM HBR 62 39 49 14
CARISOPRODOL 62 11 R 49 179
ROPINIROLE HCL 60 41 51 148
RANITIDINE HCL 59 55 52 31
DILTIAZEM 24HR ER 56 47 53 78
PLAVIX 55 47 54 79
TERAZOSIN HCL 54 53 55 76
LANTUS SOLOSTAR 53 43 56 136
ISOSORBIDE MONONITRATE ER 52 49 57 48
PEN NEEDLE 51 34 58 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.